DawnayA., MillerD.Glycation and advanced end-product formation with icodextrin and glucose.Perit Dial Int1997; 17: 52–9.
2.
KredietR., MujaisS.Use of icodextrin in high transport failure.Kidney Int Suppl2002; 81: S53–61.
3.
DoumaC., HiralallK.Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.Kidney Int1998; 53: 1014–21.
GokalR.Metabolic and laboratory effects of icodextrin.Kidney Int Suppl2002; 81: S62–71.
6.
PeersE., GokalR.Icodextrin: Overview of clinical experience.Perit Dial Int1997; 17: 22–6.
7.
Del RossoG., Di LiberatoL., PerilliA., CappelliP., BonominiM.A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient.Nephrol Dial Transplant2000; 15: 927–8.
8.
TangM., BendingM.Icodextrin hypersensitivity in a CAPD patient.Perit Dial Int1997; 17: 82–4.
9.
RobertsonS., HuxtableH., BlakemoreC., WilliamsG., DonovanK.L.The icodextrin black line sign.Perit Dial Int2001; 21: 621–3.
10.
TomasikP., SchillingC.H.Complexes of starch with inorganic guests. In: HortonD., ed. Advances in Carbohydrate Chemistry and Biochemistry. Vol. 53.San Diego, CA: Academic Press; 1998: 263–328.